@SebastienBZ @addict38 @couteronjp @parissanstabac @FedeAddiction @FFAddictologie @Addict_Aide @JeNeFumePlus @respadd @FarsalinosK Rien de préciser sur une substitution en nicotine pour les fumeurs en USI. Si on ne s'en tient pas au titre - pas très transp
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @trogersresearch: Cardiovascular Disease, Drug Therapy, and Mortality in #COVID19: new paper in NEJM. https://t.co/gUIe1zPvIF #CVD http…
RT @trogersresearch: Cardiovascular Disease, Drug Therapy, and Mortality in #COVID19: new paper in NEJM. https://t.co/gUIe1zPvIF #CVD http…
RT @GilbertDeray: Les barres à droite de la ligne verticale indiquent les facteurs qui augmente le risque de mortalité intra hospitalière.…
RT @GilbertDeray: Les barres à droite de la ligne verticale indiquent les facteurs qui augmente le risque de mortalité intra hospitalière.…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @Nephro_Sparks: Big update to #covidace2 👇
RT @vass_vassiliou: Multiple articles @NEJM on cardiovascular and #covid - certainly ACE I / ARB are faring well! https://t.co/k1cxFkuDAP &…
Big update to #covidace2 👇
On en meure plus mais on l'attrape moins... Quelqu'un peut nous aider à peser le pour ou le contre ?
RT @EmilioAlegre1: Análisis multivariante con 9000 pacientes. Tomar IECA para enfermedad cardiovascular no perjudica si se sufre COVID-19,…
RT @dr_pampers: Curti muito esse estudo aqui. Só fiquei curioso pq não colocaram obesidade/sobrepeso pra análise, seria bem interessante.…
RT @hswapnil: Big update on #NephJC #COVIDACE2 page Link https://t.co/vwnT0YMkQw Added the three NEJM studies: Mehra: https://t.co/mMPCZb…
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/dvXuV9whfB
RT @dr_pampers: Curti muito esse estudo aqui. Só fiquei curioso pq não colocaram obesidade/sobrepeso pra análise, seria bem interessante.…
Underlying cardiovascular disease associated with an increased risk of in-hospital death among 8910 patients with #COVID19. No association of ACEi/ARBs with in-hospital death. @MRMehraMD @SreyRam @HenrytTimothy @DoctorAmitPatel https://t.co/DmbDocUQ7V
RT @hswapnil: Big update on #NephJC #COVIDACE2 page Link https://t.co/vwnT0YMkQw Added the three NEJM studies: Mehra: https://t.co/mMPCZb…
RT @ValdivielsoP: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/P4P8OZei6G Aunque es un estudio obser…
RT @dermatopoulos: L’étude de 8190 patients dans 160 hôpitaux confirme le dur risque de décès en cas de maladie coronarienne, insuffisance…
RT @toyosh: 心血管系疾患、高血圧患者さんに対するACE阻害薬は、#COVID19 に対して、少なくとも有害ではない(むしろ有益)という大規模な観察研究がNEJMからpublishされました。懸念を払拭出来たことは大きいです。
RT @Neuro24de: @TheEconomist Patients who died were also more likely to have had COPD and a history of current smoking. https://t.co/c7Yj1…
@TheEconomist Patients who died were also more likely to have had COPD and a history of current smoking. https://t.co/c7Yj1DCAo8
RT @EmilioAlegre1: Análisis multivariante con 9000 pacientes. Tomar IECA para enfermedad cardiovascular no perjudica si se sufre COVID-19,…
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/P4P8OZei6G Aunque es un estudio observacional, ni IECA, ni ARAII (¡ni estatinas!!) empeoran el pronóstico vital de la COVID19
RT @Wdekanter: RT Factors found to be independently associated with an increased risk of in-hospital death: age, COPD, smoking: #corona…
RT @JSheltzer: New data in @NEJM: smoking increases your chances of dying from #COVID19 by 80%. If you have COPD, COVID19 mortality is trip…
Sehr gute aktuelle Studie zur Quantifizierung der Risikofaktoren u.a. Herz-Kreislauf-Erkrankungen, medikamentöse Therapie und Mortalität bei Covid-19 https://t.co/c7Yj1DCAo8
RT @EmilioAlegre1: Análisis multivariante con 9000 pacientes. Tomar IECA para enfermedad cardiovascular no perjudica si se sufre COVID-19,…
Análisis multivariante con 9000 pacientes. Tomar IECA para enfermedad cardiovascular no perjudica si se sufre COVID-19, al contrario. Un factor de protección para explorar. https://t.co/v2koZeIcHV
RT @JSheltzer: New data in @NEJM: smoking increases your chances of dying from #COVID19 by 80%. If you have COPD, COVID19 mortality is trip…
RT @PolemicTMM: Statins reduce covid risks New England Journal of Medicine. 1st May. https://t.co/4hPRYYpUKm https://t.co/BpyNkMeDu2
RT @PolemicTMM: Statins reduce covid risks New England Journal of Medicine. 1st May. https://t.co/4hPRYYpUKm https://t.co/BpyNkMeDu2
RT @Globalbiosec: Study finds ACEI not associated with #COVID19 mortality. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19…
RT @Globalbiosec: Important study showing #statins and #ACE inhibitors protective - ARBs possibly increase risk from #COVID19 but non-signi…
RT @PolemicTMM: Statins reduce covid risks New England Journal of Medicine. 1st May. https://t.co/4hPRYYpUKm https://t.co/BpyNkMeDu2
RT @PolemicTMM: Statins reduce covid risks New England Journal of Medicine. 1st May. https://t.co/4hPRYYpUKm https://t.co/BpyNkMeDu2
Statins reduce covid risks New England Journal of Medicine. 1st May. https://t.co/4hPRYYpUKm https://t.co/BpyNkMeDu2
RT @Globalbiosec: Study finds ACEI not associated with #COVID19 mortality. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19…
RT @Globalbiosec: Important study showing #statins and #ACE inhibitors protective - ARBs possibly increase risk from #COVID19 but non-signi…
RT @hswapnil: Big update on #NephJC #COVIDACE2 page Link https://t.co/vwnT0YMkQw Added the three NEJM studies: Mehra: https://t.co/mMPCZb…
RT @hswapnil: Big update on #NephJC #COVIDACE2 page Link https://t.co/vwnT0YMkQw Added the three NEJM studies: Mehra: https://t.co/mMPCZb…
RT @hswapnil: Big update on #NephJC #COVIDACE2 page Link https://t.co/vwnT0YMkQw Added the three NEJM studies: Mehra: https://t.co/mMPCZb…
Big update on #NephJC #COVIDACE2 page Link https://t.co/vwnT0YMkQw Added the three NEJM studies: Mehra: https://t.co/mMPCZba1wb Reynolds: https://t.co/EIuUcAY7Yg Mancia: https://t.co/1Tj81XdORg #COVID4MDs
RT @JSheltzer: New data in @NEJM: smoking increases your chances of dying from #COVID19 by 80%. If you have COPD, COVID19 mortality is trip…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @SreyRam: Our @NEJM study of 8,910 patients from 169 hospitals in Asia, Europe & North America showed #cardiovascular dx, #smoking & #CO…
RT @JSheltzer: New data in @NEJM: smoking increases your chances of dying from #COVID19 by 80%. If you have COPD, COVID19 mortality is trip…
RT @Chr1stenJohn: @AriaFrescaaaaaa @groenlinks Scherp opgemerkt. Het verband met ammoniak is niet te maken voor COVID19. Het verband met lu…
"Factors we found to be associated with an increased risk of in-hospital death were an age greater than 65 years, coronary artery disease, heart failure, cardiac arrhythmia, chronic obstructive pulmonary disease, & current smoking." #COVID19 #Comorbidi
RT @JSheltzer: New data in @NEJM: smoking increases your chances of dying from #COVID19 by 80%. If you have COPD, COVID19 mortality is trip…
https://t.co/q8IluygPXc. Great discussion in our #COVIDー19 #journalclub about this large multi-national observational study, showing that cardiovascular diseases are independently associated with risk of mortality with COVID-19, and finds no evidence of h
@AriaFrescaaaaaa @groenlinks Scherp opgemerkt. Het verband met ammoniak is niet te maken voor COVID19. Het verband met luchtvervuiling ligt voor de hand gezien de rol van roken en COPD. https://t.co/i05lvtyVsM https://t.co/3MT5UOYvpN
RT @ENERI_BSAS: Factores de riesgo: #COVID19 #Mayores de 65 años #EnfermedadCoronaria #EnfermedadCardíaca congestiva #arritmia #EPOC #Taba…
Une étude qui montre que fumer augmente le risque de décès lors du COVID de 80%. Et avoir une BPCO multiplie le risque par 3. En revanche pas d'augmentation du risque chez les anciens fumeurs. Arrêtez de fumer est la meilleure chose à faire. https://t.co/
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @JSheltzer: New data in @NEJM: smoking increases your chances of dying from #COVID19 by 80%. If you have COPD, COVID19 mortality is trip…
RT @adelarosahdez: @zigorMM @marcribass Buen hilo y explicaciones para calmar el ansía de los deportistas pero ojo, la muerte súbita extrah…
RT @JJ_Boogie: "In addition, however, concern has been expressed that medical therapy for cardiovascular disease might specifically contrib…
1/ Risk factors for death from Covid19. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/LvaTOHpWvJ
@zigorMM @marcribass Buen hilo y explicaciones para calmar el ansía de los deportistas pero ojo, la muerte súbita extrahospitalaria ha aumentado muchísimo durante el confinamiento. https://t.co/9Fd8WO5g9j
RT @ProfGRoberts: That makes more sense. #covid19
Curti muito esse estudo aqui. Só fiquei curioso pq não colocaram obesidade/sobrepeso pra análise, seria bem interessante. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/V98UNNmzOs
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @TedRader4MD: So there is actually a physiologic basis for statins being protective in lung injury. https://t.co/XFFAe5t3Lf
Cardiovascular Disease, Drug Therapy, and Mortality in #COVID19: new paper in NEJM. https://t.co/gUIe1zPvIF #CVD https://t.co/6CHYu5fjVO
Weder ACE-Hemmer noch Angiotensin-Rezeptor-Blocker erhöhen das Risiko, an COVID schwer zu erkranken https://t.co/jfXrMWeeIq
RT @BulentTutluoglu: Yüksek tansiyonu olup ACE inhibitörü tansiyon ilacı kullananlarda tansiyon ilacını değiştirmeye gerek yok . Şüpheleri…
RT @JSheltzer: New data in @NEJM: smoking increases your chances of dying from #COVID19 by 80%. If you have COPD, COVID19 mortality is trip…
RT @JJ_Boogie: "In addition, however, concern has been expressed that medical therapy for cardiovascular disease might specifically contrib…
RT @JJ_Boogie: "In addition, however, concern has been expressed that medical therapy for cardiovascular disease might specifically contrib…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Cardiovascular Disease, Drug Therapy, and Mortality in #covid19 | @NEJM https://t.co/x385O1nnEj Smoking hurts... ACEi don't.
"In addition, however, concern has been expressed that medical therapy for cardiovascular disease might specifically contribute to the severity of illness in patients with Covid-19." @MonicaPerezShow @freedomactradio https://t.co/LauVfRhsRS
RT @JSheltzer: New data in @NEJM: smoking increases your chances of dying from #COVID19 by 80%. If you have COPD, COVID19 mortality is trip…
RT @zakkohane: Important clinical [research] question for #COVID19 from this @NEJM observational study https://t.co/gkAKRSWFIM Are impressi…
RT @JJ_Boogie: "concern has been expressed that medical therapy for cardiovascular disease might specifically contribute to the severity of…
RT @SIAC_cardio: Estudio reciente de @NEJM 8910 pts con #COVID19 (Dic - Marzo) - 5,8% ☠️ -Edad y enf. CV⏩factores asociados a mortalidad…
"concern has been expressed that medical therapy for cardiovascular disease might specifically contribute to the severity of illness in patients with Covid-19" https://t.co/LauVfQZRti
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @docmmiller: It would be nice if there were metrics other than death, eg serious respiratory distress, days sick etc. Death is one endpo…
RT @JSheltzer: New data in @NEJM: smoking increases your chances of dying from #COVID19 by 80%. If you have COPD, COVID19 mortality is trip…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @ENERI_BSAS: Factores de riesgo: #COVID19 #Mayores de 65 años #EnfermedadCoronaria #EnfermedadCardíaca congestiva #arritmia #EPOC #Taba…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @JSheltzer: New data in @NEJM: smoking increases your chances of dying from #COVID19 by 80%. If you have COPD, COVID19 mortality is trip…
Factores de riesgo: #COVID19 #Mayores de 65 años #EnfermedadCoronaria #EnfermedadCardíaca congestiva #arritmia #EPOC #Tabaquismo #HipertensiónArterial Artículo completo https://t.co/xVlMeOy9iv #ENERI @SAGRADA_BSAS @eneri_neuro #Coronavirus #covid20
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 https://t.co/gUs3UwPSPK?
RT @drFelipeHuaier: Casi 9000 pacientes de distintos lugares del mundo a desmentir los mitos sobre mortalidad y uso de drogas para hiperten…
RT @JSheltzer: New data in @NEJM: smoking increases your chances of dying from #COVID19 by 80%. If you have COPD, COVID19 mortality is trip…